5AM Opportunities II (GP), LLC 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-30 4:10 pm Purchase | 2025-12-18 | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | 5AM Opportunities II (GP), LLC | 4,838,571 6.400% | 4,838,571 (New Position) | Filing |